MILAN, 5 février 2025 /PRNewswire/ — Newronika, développeur d’une technologie révolutionnaire de stimulation cérébrale profonde adaptative, est fier d’annoncer l’obtention d’une exemption de dispositif expérimental (IDE) de la Food and Drug Administration (FDA) des États-Unis….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.